Endometriosis

KT Zondervan, CM Becker, K Koga, SA Missmer, RN Taylor, P Viganò

Research output: Contribution to journalArticle

Abstract

Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, mainly on pelvic organs and tissues. It affects ~5–10% of women in their reproductive years — translating to 176 million women worldwide — and is associated with pelvic pain and infertility. Diagnosis is reliably established only through surgical visualization with histological verification, although ovarian endometrioma and deep nodular forms of disease can be detected through ultrasonography and MRI. Retrograde menstruation is regarded as an important origin of the endometrial deposits, but other factors are involved, including a favourable endocrine and metabolic environment, epithelial–mesenchymal transition and altered immunity and inflammatory responses in genetically susceptible women. Current treatments are dictated by the primary indication (infertility or pelvic pain) and are limited to surgery and hormonal treatments and analgesics with many adverse effects that rarely provide long-term relief. Endometriosis substantially affects the quality of life of women and their families and imposes costs on society similar to those of other chronic conditions such as type 2 diabetes mellitus, Crohn’s disease and rheumatoid arthritis. Future research must focus on understanding the pathogenesis, identifying disease subtypes, developing non-invasive diagnostic methods and targeting non-hormonal treatments that are acceptable to women who wish to conceive. © 2018, Macmillan Publishers Ltd., part of Springer Nature.
Original languageEnglish
Article number9
JournalNature Reviews Disease Primers
Volume4
DOIs
Publication statusPublished - 2018

Fingerprint

Endometriosis
Pelvic Pain
Infertility
Menstruation Disturbances
Endometrium
Crohn Disease
Type 2 Diabetes Mellitus
Uterus
Analgesics
Immunity
Ultrasonography
Rheumatoid Arthritis
Therapeutics
Quality of Life
Costs and Cost Analysis

Cite this

Zondervan, KT., Becker, CM., Koga, K., Missmer, SA., Taylor, RN., & Viganò, P. (2018). Endometriosis. Nature Reviews Disease Primers, 4, [9]. https://doi.org/10.1038/s41572-018-0008-5

Endometriosis. / Zondervan, KT; Becker, CM; Koga, K; Missmer, SA; Taylor, RN; Viganò, P.

In: Nature Reviews Disease Primers, Vol. 4, 9, 2018.

Research output: Contribution to journalArticle

Zondervan, KT, Becker, CM, Koga, K, Missmer, SA, Taylor, RN & Viganò, P 2018, 'Endometriosis', Nature Reviews Disease Primers, vol. 4, 9. https://doi.org/10.1038/s41572-018-0008-5
Zondervan KT, Becker CM, Koga K, Missmer SA, Taylor RN, Viganò P. Endometriosis. Nature Reviews Disease Primers. 2018;4. 9. https://doi.org/10.1038/s41572-018-0008-5
Zondervan, KT ; Becker, CM ; Koga, K ; Missmer, SA ; Taylor, RN ; Viganò, P. / Endometriosis. In: Nature Reviews Disease Primers. 2018 ; Vol. 4.
@article{d11ec3ce13714719b8007bbd336c062e,
title = "Endometriosis",
abstract = "Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, mainly on pelvic organs and tissues. It affects ~5–10{\%} of women in their reproductive years — translating to 176 million women worldwide — and is associated with pelvic pain and infertility. Diagnosis is reliably established only through surgical visualization with histological verification, although ovarian endometrioma and deep nodular forms of disease can be detected through ultrasonography and MRI. Retrograde menstruation is regarded as an important origin of the endometrial deposits, but other factors are involved, including a favourable endocrine and metabolic environment, epithelial–mesenchymal transition and altered immunity and inflammatory responses in genetically susceptible women. Current treatments are dictated by the primary indication (infertility or pelvic pain) and are limited to surgery and hormonal treatments and analgesics with many adverse effects that rarely provide long-term relief. Endometriosis substantially affects the quality of life of women and their families and imposes costs on society similar to those of other chronic conditions such as type 2 diabetes mellitus, Crohn’s disease and rheumatoid arthritis. Future research must focus on understanding the pathogenesis, identifying disease subtypes, developing non-invasive diagnostic methods and targeting non-hormonal treatments that are acceptable to women who wish to conceive. {\circledC} 2018, Macmillan Publishers Ltd., part of Springer Nature.",
author = "KT Zondervan and CM Becker and K Koga and SA Missmer and RN Taylor and P Vigan{\`o}",
year = "2018",
doi = "10.1038/s41572-018-0008-5",
language = "English",
volume = "4",
journal = "Nature Reviews Disease Primers",
issn = "2056-676X",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Endometriosis

AU - Zondervan, KT

AU - Becker, CM

AU - Koga, K

AU - Missmer, SA

AU - Taylor, RN

AU - Viganò, P

PY - 2018

Y1 - 2018

N2 - Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, mainly on pelvic organs and tissues. It affects ~5–10% of women in their reproductive years — translating to 176 million women worldwide — and is associated with pelvic pain and infertility. Diagnosis is reliably established only through surgical visualization with histological verification, although ovarian endometrioma and deep nodular forms of disease can be detected through ultrasonography and MRI. Retrograde menstruation is regarded as an important origin of the endometrial deposits, but other factors are involved, including a favourable endocrine and metabolic environment, epithelial–mesenchymal transition and altered immunity and inflammatory responses in genetically susceptible women. Current treatments are dictated by the primary indication (infertility or pelvic pain) and are limited to surgery and hormonal treatments and analgesics with many adverse effects that rarely provide long-term relief. Endometriosis substantially affects the quality of life of women and their families and imposes costs on society similar to those of other chronic conditions such as type 2 diabetes mellitus, Crohn’s disease and rheumatoid arthritis. Future research must focus on understanding the pathogenesis, identifying disease subtypes, developing non-invasive diagnostic methods and targeting non-hormonal treatments that are acceptable to women who wish to conceive. © 2018, Macmillan Publishers Ltd., part of Springer Nature.

AB - Endometriosis is a common inflammatory disease characterized by the presence of tissue outside the uterus that resembles endometrium, mainly on pelvic organs and tissues. It affects ~5–10% of women in their reproductive years — translating to 176 million women worldwide — and is associated with pelvic pain and infertility. Diagnosis is reliably established only through surgical visualization with histological verification, although ovarian endometrioma and deep nodular forms of disease can be detected through ultrasonography and MRI. Retrograde menstruation is regarded as an important origin of the endometrial deposits, but other factors are involved, including a favourable endocrine and metabolic environment, epithelial–mesenchymal transition and altered immunity and inflammatory responses in genetically susceptible women. Current treatments are dictated by the primary indication (infertility or pelvic pain) and are limited to surgery and hormonal treatments and analgesics with many adverse effects that rarely provide long-term relief. Endometriosis substantially affects the quality of life of women and their families and imposes costs on society similar to those of other chronic conditions such as type 2 diabetes mellitus, Crohn’s disease and rheumatoid arthritis. Future research must focus on understanding the pathogenesis, identifying disease subtypes, developing non-invasive diagnostic methods and targeting non-hormonal treatments that are acceptable to women who wish to conceive. © 2018, Macmillan Publishers Ltd., part of Springer Nature.

U2 - 10.1038/s41572-018-0008-5

DO - 10.1038/s41572-018-0008-5

M3 - Article

VL - 4

JO - Nature Reviews Disease Primers

JF - Nature Reviews Disease Primers

SN - 2056-676X

M1 - 9

ER -